Ok...I don’t know how emgromed has $12m; the study could fail and emgromed walks with the same data as cvm...leaving cvm worthless (essentially my worse case scenario)
In event ph3 fails is does the data itself hold value if somebody else has it....or would it be of more value if only cvm had it?
Try looking through this lense:
Engromed gets access to all. You all seem to interpret engromed as “in need” and dependent on “cvm ph3 MK”.
You ever think engromed feels/ accounts as if they are getting paid to do what they Already do and gain access to the only given within the study framework? Failure or. Not? The data....
Does anybody think engromed is a charity?
Enrofmed was like “hey, there is this genius guy geert doing to study and he’s paying big bucks...he’s fire sales everything, albeit he’s at the end.. he’s been toxic diluter , internal financing....
But, cvm is at the end, they have money, a facilty, the have shares...
Short story: engromed was in the money via data trap since day one....why else accept at the market shares?
Duh? Is logic kicking in yet? It actually demonstrates a good deal by geert “at this moment”....And a faith deal “at this moment “
I’m stifling, but think I found an analogy.....
A billboard....
Engromed does billboards....
Cvm sells med
Billboard is vacant
Cvm says we want to advertise...on your billboard that
Engromed gets paid by cvm to post the ad (billboard)
But they also get results of effectiveness of the ad...etc....
This glassware clearly and logically implies engromed is getting paid prior to any valuation of the product they actual ly sell...
In other word , it could be construed as a longevity asset that is in reality being rented at a premium plus “bonus!”
News 
Market Data 
Discover 
